Results 11 to 20 of about 143,744 (251)

Role of tumor-derived exosomes in metastasis, drug resistance and diagnosis of clear cell renal cell carcinoma

open access: yesFrontiers in Oncology, 2022
Renal cancer is one of the most extensively studied human tumors today, with clear cell renal cell carcinoma accounting for approximately 80% of all cases.
Tiancheng Jiang   +9 more
doaj   +1 more source

The long noncoding RNA urothelial carcinoma-associated 1 overexpression as a poor prognostic biomarker in clear cell renal cell carcinoma

open access: yesTumor Biology, 2017
Long noncoding RNA urothelial carcinoma-associated 1 has previously played important roles in cancer. However, its role is still unknown in clear cell renal cell carcinoma.
Yang Wang   +4 more
doaj   +1 more source

Clear Cell Renal Cell Carcinoma: Local Recurrence and Bilateral Adrenal Metastases - A Case Report

open access: yesJournal of the Belgian Society of Radiology, 2022
Introduction: Clear cell renal cell carcinoma is the most frequent type of renal cell carcinoma, which is often diagnosed incidentally in an advanced stage.
Eliza-Maria Popa   +2 more
doaj   +1 more source

Overexpression of TRIM2 suppresses proliferation, migration and stemness of clear cell renal cell carcinoma cells in vitro

open access: yesDi-san junyi daxue xuebao, 2019
Objective To explore the effect of tripartite motif-containing protein 2 (TRIM2) on the proliferation, migration and stemness of clear cell renal clear carcinoma.
LUO Xing   +4 more
doaj   +1 more source

Synchronous bilateral renal cell carcinomas with differing histologies

open access: yesIJU Case Reports, 2020
Introduction Bilateral renal cell carcinomas with different histological types are rare. We report herein the first description of bilateral renal carcinomas with clear cell renal cell carcinoma and mucinous tubular and spindle cell carcinoma occurring ...
Ryu Shigehisa   +9 more
doaj   +1 more source

Antigenic targets in clear cell renal cell carcinoma

open access: yesKidney Cancer, 2023
Immune checkpoint inhibitors (ICIs) have transformed the management of advanced renal cell carcinoma (RCC), but most patients still do not receive a long-term benefit from these therapies, and many experience off-target, immune-related adverse effects ...
Nicholas R. Schindler, David A. Braun
doaj   +1 more source

Heart Metastases of Clear Cell Renal Cell Carcinoma

open access: yesDiagnostics, 2023
Renal cell carcinoma (RCC) is a common genitourinary cancer. Of the several histologic types of RCC, clear cell renal cell carcinoma (ccRCC) is the most frequent.
Katarzyna Romejko   +3 more
doaj   +1 more source

Clear cell renal cell carcinoma and papillary renal cell carcinoma: differentiation of distinct histological types with multiphase CT

open access: yesDiagnostic and Interventional Radiology, 2013
PURPOSEConventional clear cell renal cell carcinoma (ccRCC) and papillary renal cell carcinoma (pRCC) have different behavioral characteristics and clinical management strategies (nephrectomy vs. nephron-sparing surgery).
Pal Bata   +10 more
doaj   +1 more source

Risk Factors and Histopathological Features of Renal Cell Carcinoma Subtypes [PDF]

open access: yesTranslational Research in Urology, 2022
Introduction: Kidney cancer is currently the 9th most common cancer in men and the 14th most common in women. Renal cell carcinoma (RCC) is the most common type of kidney cancer, accounting for about 85% of all renal malignancies. It accounts for about 2%
Anahita Ansari Djafari   +8 more
doaj   +1 more source

Clinical utility of MCM2 and CD44 expression in clear cell renal cell carcinoma

open access: yesPolish Journal of Pathology, 2021
Clear cell renal cell carcinoma (ccRCC) has an unpredictable clinical consequence even with the use of usual prognostic factors. To determine whether utilization of cell proliferation and cell adhesion by using MCM2 and CD44 immuno-expression could ...
Mariana F. Gayyed   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy